Literature DB >> 8699029

Type-specific serologic diagnosis of respiratory syncytial virus infection, based on a synthetic peptide of the attachment protein G.

J P Langedijk1, W G Middel, W M Schaaper, R H Meloen, J A Kramps, A H Brandenburg, J T van Oirschot.   

Abstract

Peptides deduced from the central hydrophobic region (residues 158-189) of the G protein of bovine and ovine respiratory syncytial virus (RSV) and of human RSV subtypes A and B were synthesized. These peptides were used to develop ELISAs to measure specifically antibodies against these types and subtypes of RSV. We have evaluated the bovine RSV-G peptide in both an indirect ELISA and in a blocking ELISA. Specificity and sensitivity, relative to a routine diagnostic ELISA that detects antibodies against the RSV F-protein in bovine sera, were 98% and 92% respectively for the indirect peptide-based ELISA, and 98% and 98% for the blocking peptide-based ELISA. In paired serum samples, rises in antibody titer were detected more frequently with the indirect peptide-based ELISA than with the routine F-ELISA. Furthermore, the peptide-based G-ELISAs were able to differentiate between antibodies against BRSV and HRSV, and between those against BRSV and ORSV. In addition, the indirect peptide-based ELISA was selective for HRSV subtype A and B antibodies. This study shows that peptides, corresponding to the central hydrophobic region of the attachment protein G of several RSVs, can be used successfully as antigens in highly specific and sensitive immunoassays.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699029     DOI: 10.1016/0022-1759(96)00039-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Antibody response to the central unglycosylated region of the respiratory syncytial virus attachment protein in mice.

Authors:  Yoshihiko Murata; Seana C Catherman
Journal:  Vaccine       Date:  2012-06-19       Impact factor: 3.641

2.  Enzyme-linked immunosorbent assay using a virus type-specific peptide based on a subdomain of envelope protein E(rns) for serologic diagnosis of pestivirus infections in swine.

Authors:  J P Langedijk; W G Middel; R H Meloen; J A Kramps; J A de Smit
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 3.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

4.  A subtype-specific peptide-based enzyme immunoassay for detection of antibodies to the G protein of human respiratory syncytial virus is more sensitive than routine serological tests.

Authors:  J P Langedijk; A H Brandenburg; W G Middel; A Osterhaus; R H Meloen; J T van Oirschot
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

5.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

Review 6.  Bovine respiratory syncytial virus (BRSV): a review.

Authors:  L E Larsen
Journal:  Acta Vet Scand       Date:  2000       Impact factor: 1.695

7.  Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.

Authors:  J P Langedijk; R H Meloen; G Taylor; J M Furze; J T van Oirschot
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis.

Authors:  Adriaan F G Antonis; Remco S Schrijver; Franz Daus; Paul J G M Steverink; Norbert Stockhofe; Evert J Hensen; Johannes P M Langedijk; Robbert G van der Most
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Ann R Falsey; Edward E Walsh
Journal:  Clin Vaccine Immunol       Date:  2010-02-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.